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Abstract. 
The paper presents an analysis of information awareness of pharmaceutical personnel on aspects 
of pharmaceutical aid to children with joint diseases; we analyzed the product portfolio of 
medicines for treating children with juvenile arthritis in the ambulatory outpatient conditions, 
taking into account consumer preferences and economic opportunities of their families; we 
developed a materials bank for pharmaceutical information counseling of pharmacy personnel in 
terms of pharmaceutical aid to children with joint diseases. 
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Аннотация. В статье представлены результаты анализа информационной осведомленности 
фармацевтических работников по аспектам фармацевтической помощи детям с 
заболеваниями суставов; проанализированы ассортиментные портфели лекарственных 
средств для лечения детей с юношеским артритом в амбулаторно – поликлинических 
условиях с учетом потребительских предпочтений и экономических возможностей семьи; 
разработан банк материалов для фармацевтического информационного консультирования 
работников аптек в области фармацевтической помощи детям с заболеваниями суставов. 
Ключевые слова: фармацевтическая помощь, лекарственные средства, дети, артриты, 
ассортиментные портфели, аптеки. 
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Introduction: The Joint diseases in children, 
grouped as «juvenile arthritis», tend today to the 
steady increase in the population of children and 
adolescents, which leads to higher social and medical 
significance of the problem. Pharmacotherapy of this 
nosology provides long-term outpatient and inpatient 
treatment [1, 3]. 
Children in outpatient treatment are provided 
with medicines from the pharmacies for patients’ 
own funds. However, in the case of the high cost of 
prescribed drugs, the parents who cannot afford the 
entire complex, buy it partially, or don’t buy at all. 
As a result, there is a significant decline in the quality 
of the therapy, slowing of the healing process, and, as 
a consequence, an increased likelihood of disease 
process to become chronic [2]. 
Given that the final element in providing drugs 
to outpatient patients is the pharmacy, a competent 
pharmaceutical information counseling (PIC) of 
consumers by the pharmaceutical personnel in terms 
of range of drugs comes to the fore, which 
contributes to the acquisition of the full range of 
medicines prescribed by a doctor. However, 
currently, the pharmaceutical experts incur an 
information deficit in aspects of pharmaceutical care 
in the pharmacotherapy of rare diseases, including 
diseases of the joints in children. 
In connection therewith, the optimization of 
informational support for pharmacies in the field of 
pharmaceutical aid to children with arthropathy is a 
highly relevant issue.  
Objective of this paper is the optimization of 
informational support for pharmacies in the field of 
pharmaceutical aid to children with arthropathy 
(using juvenile arthritis as an example). 
Objects of research: 300 pharmaceutical 
professionals working in Russian pharmacies; 
Internet resources: the State Register of Medicinal 
Products 2015; Encyclopedia of Drugs: Russian Drug 
Register 2015, the International Classification of 
Diseases, 10th Revision (ICD-10), Widal’s 
Handbook «Medicines in Russia» 2015, and Russian 
Public Opinion Research Center (RPORC) 
http://wciom.ru/ 
Research methods: analytical approach, 
method of ranking, graphic method, comparison 
method, and sociological method (questionnaire 
survey). 
Results and discussion. In order to optimize 
informational support for pharmacies in the field of 
pharmaceutical aid to children with arthropathy is a 
highly relevant issue, we developed a concept of 
study consisting of 3 stages. The first stage of the 
study involves theoretical aspects  of optimization of 
information support to the pharmacies in terms of 
pharmaceutical aid to children with joint diseases; the 
second stage involves analysis of information 
awareness of pharmaceutical personnel on the 
provision of pharmaceutical aid to children with joint 
diseases; and the third stage includes development of 
a materials bank for pharmaceutical information 
counseling of pharmacy personnel in terms of 
pharmaceutical aid to children with joint diseases. 
Thus, the second stage of the study involved 
sociological research in the form of full-time and part-
time (online) questionnaire survey of 300 
pharmaceutical professionals on the basis of pharmacies 
of Belgorod and other cities of Russia. On the basis 
thereof a professional portrait of a pharmaceutical 
specialist has been created. We found that it is 
a woman – 91.7%; aged 20 to 30 years – 69%; with 
specialized secondary pharmaceutical education – 
52.7%; working on a specialty from 1 to 5 years – 
56.7%; carrying out her professional activity in 
Belgorod pharmacies – 63.7%. We revealed that 87% 
of pharmaceutical specialists had in their practice the 
cases of arthritis in children; while 80.7% of 
respondents are aware of the possible causes of the 
disease; 91.7% of pharmaceutical employees are aware 
of the probability of chronic articular process and 
disability in case of delayed reference to the doctor by 
reason of pain in the joints in children. 
We determined that only 34.3% of parents refer 
to the pharmacy with the medications prescribed by 
doctor; 43.9% of patients ask a pharmaceutical 
professional to provide an advice on the choice of the 
drug in situ. It was found that in case of parents 
referring to the pharmacy with complains of joint 
pain in children, more than half of the respondents 
would dispense external or oral NSAIDs in 
accordance with the age of the child, and definitely 
advise to refer to a doctor – 51%. Conspicuous is the 
fact that about 50% of respondents indicated that 
parents often ask to replace the prescribed 
medications with cheaper equivalents. We revealed 
that the source of professional information for 
pharmaceutical professionals is reference literature – 
44.4%,  books and periodicals are used as additional 
information – 48.4%; 89.7% of respondents consider 
necessary to draw the attention of parents to the 
necessity for timely reference to the doctor upon the 
first symptoms of the joint disease in their child; 
55.1% of respondents consider visual materials to be 
the most convincing information on the need to see a 
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doctor; in particular, the thematic posters – 32.7%; 
92.3% of respondents indicated that placing such 
materials in the pharmacy will enhance the level of 
parental responsibility for children's health, as well as 
timely reference to a doctor; and 88.3% of 
respondents consider helpful to have a list of drugs in 
the pharmacy, effective for the treatment of juvenile 
arthritis, and at different price. Thus, we have 
revealed the interest of pharmaceutical professionals 
in the development of materials, which make up the 
information deficit in the matters of pharmaceutical 
aid to children with the joint diseases. 
As part of the 3rd stage of the study, we 
analyzed the drugs product portfolio of different price 
categories for the treatment of juvenile arthritis on an 
outpatient basis developed in 2013 at the Department 
of Management and Economics of Pharmacy of NRU 
«BSU» under the guidance of professor Spichak I.V. 
The portfolios have been created due to the following 
approach: to involve the drugs with the maximum 
possible consumer characteristics such as 
pharmacotherapeutic efficacy, age restrictions, price, 
ease of use, safety, and a certain price range for one 
course of treatment. 
Conclusion. We have formed a data bank (DB) 
for pharmaceutical professionals, designed to advise 
consumers on pharmaceutical and consumer 
characteristics of drugs used in treating joint diseases 
in children. The data bank includes 3 lists in three 
different price categories: «high-cost», «mid-price», 
and «low-cost» and contains summary of 
pharmaceutical and consumer characteristics of the 
described drugs and is to be placed in the pharmacy 
checkout area. 
Thus, a data bank on high-cost drugs for the 
treatment of juvenile poly-/oligoarticular arthritis 
includes 7 essential drugs (EsD) and 4 equivalent 
drugs (EqD) in accordance with the 
pharmacotherapeutic complex – disease-modifying 
agents – basic anti-inflammatory drugs; the drugs 
affecting the blood system and blood formation; 
symptom-modifying agents. Average cost per course 
of treatment amounts up to 7,600 rubles. The 
medicines of the above complex are original, have a 
high pharmacotherapeutic effect and consumer 
features, however cost-intensive.The mid-price list in 
the data bank contains 7 EsD and 6 EqD. The 
estimated cost per course of treatment amounts up to 
4,600 rubles. The low-cost list in the data bank with 
the average cost per course of treatment up to 1,600 
rubles includes 8 EsD and 8 EqD, which are usually 
the domestic products, having successfully proven 
themselves in the treatment of this pathology. 
The developed materials are presented for the 
purpose of creation of a pharmacy product portfolio 
policy in the field of drugs for the treatment of joint 
diseases in children, which will ensure optimization 
of the advice of pharmaceutical professional to 
parents on the choice of children's medicines based 
on the doctor's prescriptions, and fully meet the 
client’s information needs. 
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Table 
A fragment of a data bank on mid-price drugs for juvenile poly-/oligoarticular arthritis in children (the estimated cost per course of treatment amounts up to 4,600 rubles) 
Essential drug 
No. Trade 
name 
INN Type 
of 
drug 
PF, dosage Manufacturing 
country 
Dispensing 
requirements 
Age 
restrictions 
Dosage regimen Note 
Nonsteroidal anti-inflammatory drugs (NSAIDs) 
Symptomatic therapy of articular syndrome: anti-inflammatory, analgesic effect. 
The drugs are prescribed prior to a regression of the articular syndrome and normalization of laboratory test values. 
1 
Mataren 
Meloxicamum 
G
en
er
ic
 d
ru
g
 
Tablets 7.5 
mg No. 20 
R
u
ss
ia
 Dispense on 
prescription 
Prescription form No. 
107/У 
From age 
12 
Per os. 15mg/day, after positive therapeutic effect the 
dose can be reduced to 7.5 mg/day 
With food 
2 
Voltaren 
Emulgel Diclophenacum 
O
ri
g
in
al
 d
ru
g
 
gel 1%, 20 
g 
S
w
it
ze
rl
an
d
 
Pharmacy dispensing – 
over-the-counter 
From age 
12 
Topical Drug amount to apply depends on the size of 
trigger area. A single dose – 2-4 gram (comparable to 
the size of a cherry or walnut) is sufficient to cover the 
400-800 cm2 area 
The drug is applied to 
the skin 3-4 times/day 
with gentle massage 
3 
Nurofen 
for 
children 
Ibuprofen 
G
en
er
ic
 d
ru
g
 
oral 
suspension 
100 mg/5 
ml 
G
re
at
 B
ri
ta
in
 
Pharmacy dispensing – 
over-the-counter 
Per os. Children aged 3 to 6 months – 2.5 ml, 3 times a day (not more than 150 mg/day); 6 to 12 
months – 2.5 ml 3-4 times a day (maximum 200 mg/day); 1 year to 3 years – 5 ml 3 times a day 
(not more than 300 mg/day); 4 to 6 years – 7.5 ml 3 times per day (up to 450 mg/day); 7 to 9 years 
– 10 ml 3 times per day (up to 600 mg/day); 10 to 12 years – 15 ml 3 times per day (up to 900
mg/day) 
4 
Nise 
Nimesulidum 
O
ri
g
in
al
 d
ru
g
 
dispersible 
tablets 50 
mg No.20 I
n
d
ia
 Dispense on 
prescription 
Prescription form No. 
107/У 
From age 2 
Per os. 100 mg 2 times a day 
before meals (pour the sachet 
content into a glass and dissolve in 
water), for 7-14 days 
In case of discomfort in the 
stomach, the drug can be taken at 
the end or after a meal 
5 Nise Nimesulidum 
O
ri
g
in
al
 
d
ru
g
 
gel 1%, 20 
g 
In
d
ia
 Pharmacy dispensing – 
over-the-counter 
From age 7 Topical Apply a uniform thin layer of 3 cm gel column on the area of 
maximum tenderness, do not rub, 3-4 times/day. 
6 Indovasin Indomethacinum 
+ Troxerutinum 
O
ri
g
in
al
 
d
ru
g
 gel for 
external 
use B
u
lg
ar
ia
 
Pharmacy dispensing – 
over-the-counter 
From age 14 Topical Apply 4-5 cm of a thin gel layer on the affected area with gentle 
massaging movements 
